Work

Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.

Year: 2002

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Arthur E Frankel, Bayard L Powell, Philip D Hall, L Douglas Case, Robert J Kreitman

Institutions: Atrium Health Wake Forest Baptist, Wake Forest University

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Awards: Combination fusion toxin and cytarabine therapy of AML, Diphtheria fusion protein therapy of AML, General Clinical Research Center

OpenAlex ID: W2162539008

FWCI: 3.999

Cites: 30

Cited by: 113

Related to: 10